454 results on '"Pokushalov, Evgeny"'
Search Results
2. Effect of Methylfolate, Pyridoxal-5′-Phosphate, and Methylcobalamin (SolowaysTM) Supplementation on Homocysteine and Low-Density Lipoprotein Cholesterol Levels in Patients with Methylenetetrahydrofolate Reductase, Methionine Synthase, and Methionine Synthase Reductase Polymorphisms: A Randomized Controlled Trial
3. EVALUATING THE IMPACT OF OMEGA-3 FATTY ACID SUPPLEMENTATION ON LIPID PROFILES IN ADULTS WITH PPARG POLYMORPHISMS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
4. EFFECT OF METHYLFOLATE, PYRIDOXAL-5’-PHOSPHATE, AND METHYLCOBALAMIN SUPPLEMENTATION ON HOMOCYSTEINE AND LDL-C LEVELS IN PATIENTS WITH MTHFR, MTR, AND MTRR POLYMORPHISMS
5. Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial.
6. Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study.
7. The Impact of Glucomannan, Inulin, and Psyllium Supplementation (SolowaysTM) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial
8. Atrial Fibrillation Burden and Clinical Outcomes in Heart Failure: The CASTLE-AF Trial
9. Effect of Methylfolate, Pyridoxal-5′-Phosphate, and Methylcobalamin (Soloways TM) Supplementation on Homocysteine and Low-Density Lipoprotein Cholesterol Levels in Patients with Methylenetetrahydrofolate Reductase, Methionine Synthase, and Methionine Synthase Reductase Polymorphisms: A Randomized Controlled Trial
10. Evaluating the Impact of Omega-3 Fatty Acid (SolowaysTM) Supplementation on Lipid Profiles in Adults with PPARG Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial
11. High-resolution, real-time, and nonfluoroscopic 3-dimensional cardiac imaging and catheter navigation in humans using a novel dielectric-based system
12. Evaluating the impact of omega-3 fatty acid supplementation on lipid profiles in adults with PPARG polymorphisms: A randomized, double-blind, placebo-controlled trial
13. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study
14. The Impact of Glucomannan, Inulin, and Psyllium Supplementation (Soloways TM) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial.
15. Evaluating the Impact of Omega-3 Fatty Acid (Soloways TM) Supplementation on Lipid Profiles in Adults with PPARG Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial.
16. Globular chitosan prolongs the effective duration time and decreases the acute toxicity of botulinum neurotoxin after intramuscular injection in rats
17. Globular chitosan treatment of bovine jugular veins: evidence of anticalcification efficacy in the subcutaneous rat model
18. Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial
19. P203: Evaluating the impact of Omega-3 fatty acid supplementation on lipid profiles in adults with PPARG polymorphisms: Randomized, double-blind, placebo-controlled trial
20. The Evaluate Renal Artery Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERADICATE-AF) trial: arrhythmia suppression, blood pressure control, and potential interactions
21. Quality of Life after Surgical Ablation of Persistent Atrial Fibrillation: A Prospective Evaluation
22. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage
23. Sex‐related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry.
24. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary
25. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study
26. Catheter Ablation for Atrial Fibrillation with Heart Failure
27. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
28. Abstract 20395: Effects of Antiarrhythmic Drug Therapy Before and During Atrial Fibrillation Ablation on Procedure Outcomes: Results From a European Registry
29. Abstract 14988: Prophylactic Pulmonary Vein Isolation During Isthmus Ablation for Atrial Flutter: Three-Year Outcomes of the PREVENT AF I Study
30. Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial
31. Visualization and ablation of the autonomic nervous system corresponding to ganglionated plexi guided by D-SPECT 123I-mIBG imaging in patient with paroxysmal atrial fibrillation
32. Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial
33. Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate Data
34. PO-636-06 DOES RENAL ARTERY DENERVATION IN ADDITION TO PVI REDUCE AF BURDEN? RESULTS OF THE MULTICENTER ERADICATE-AF RANDOMIZED CLINICAL TRIAL
35. Meta-Analysis of Stem Cell Therapy in Chronic Ischemic Cardiomyopathy
36. Long-Term Suppression of Atrial Fibrillation by Botulinum Toxin Injection into Epicardial Fat Pads in Patients Undergoing Cardiac Surgery: One Year Follow Up of a Randomized Pilot Study
37. Intramyocardial injections of erythropoietin-analogue C.E.R.A. in ischemic cardiomyopathy: the ALSTER C.E.R.A. trial
38. Renal artery denervation: modulation of the autonomic nervous system to treat atrial fibrillation
39. Ablation of autonomic ganglia
40. Stem Cell Therapy for Electrophysiological Disorders
41. Safety Profile of a Miniaturized Insertable Cardiac Monitor: Results from Two Prospective Trials
42. B-PO05-179 A NEW CLINICAL DECISION SUPPORT TOOL BASED ON PERSONALIZED EVIDENCE-BASED MEDICINE IMPROVES OUTCOMES OF ANTICOAGULATION THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS FROM THE ATRIAL FIBRILLATION REGISTRY
43. B-PO01-075 ASSOCIATION BETWEEN PERSONALIZED EVIDENCE-BASED ANTICOAGULATION THERAPY AND OUTCOMES AT 1-YEAR FOLLOW-UP IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS FROM THE ATRIAL FIBRILLATION REGISTRY
44. Renal Denervation for Treatment of Cardiac Arrhythmias: State of the Art and Future Directions
45. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation
46. Renal Denervation for Arrhythmias: Hope or Hype?
47. Synthesis and analgesic activity of new heterocyclic compounds derived from monoterpenoids
48. Cardiac Resynchronization Therapy and Bone Marrow Cell Transplantation in Patients with Ischemic Heart Failure and Electromechanical Dyssynchrony: A Randomized Pilot Study
49. Left Atrial Appendectomy After Failed Catheter Ablation of a Focal Atrial Tachycardia Originating in the Left Atrial Appendage
50. Efficiency of Intramyocardial Injections of Autologous Bone Marrow Mononuclear Cells in Patients with Ischemic Heart Failure: A Randomized Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.